@article {1016086,
	title = {A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear},
	journal = {Nat Biotechnol},
	volume = {35},
	number = {3},
	year = {2017},
	month = {2017 Mar},
	pages = {280-284},
	abstract = {Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient, and clinically relevant delivery modalities. Here we demonstrate the safety and efficiency of Anc80L65, a rationally designed synthetic vector, for transgene delivery to the mouse cochlea. Ex vivo transduction of mouse organotypic explants identified Anc80L65 from a set of other adeno-associated virus (AAV) vectors as a potent vector for the cochlear cell targets. Round window membrane injection resulted in highly efficient transduction of inner and outer hair cells in mice, a substantial improvement over conventional AAV vectors. Anc80L65 round window injection was well tolerated, as indicated by sensory cell function, hearing and vestibular function, and immunologic parameters. The ability of Anc80L65 to target outer hair cells at high rates, a requirement for restoration of complex auditory function, may enable future gene therapies for hearing and balance disorders.},
	issn = {1546-1696},
	doi = {10.1038/nbt.3781},
	author = {Landegger, Lukas D and Pan, Bifeng and Askew, Charles and Wassmer, Sarah J and Gluck, Sarah D and Galvin, Alice and Taylor, Ruth and Forge, Andrew and Stankovic, Konstantina M and Holt, Jeffrey R and Vandenberghe, Luk H}
}
